ALZHEIMER'S DISEASE (AD)

This study tested an experimental drug called ABBV-916 in people with early Alzheimer's disease. The goal was to see if it is safe and can slow down the disease. About 106 participants received either the drug or a placebo through an IV every 4 weeks for 6 months, with an option …

This study tested a new blood test that uses a special chip to find signs of Alzheimer's disease. Researchers collected blood and urine from 150 people, including those with Alzheimer's, other brain diseases, and healthy volunteers. The goal was to see if the test could accuratel…

This study tested whether a computer software called SCALE PET helps doctors more accurately spot signs of Alzheimer's disease on brain scans. Researchers looked at 190 past scans from people with Alzheimer's or mild memory problems. Four doctors read the scans twice—once with th…

This study tested whether a special graphene far-infrared device could improve thinking and memory in 126 older adults with mild cognitive decline or Alzheimer's disease. Participants used the device or a placebo for 4 weeks. The goal was to see if this heat-based therapy could e…

This study tested whether a procedure called a stellate ganglion block (SGB), given with standard medication, could improve thinking and memory in people with Alzheimer's disease. Forty participants were randomly assigned to receive either SGB plus standard drugs or standard drug…

This study tested an experimental drug called ABBV-552 in 263 people with mild Alzheimer's disease. Participants took the drug or a placebo daily for 12 weeks to see if it improved memory and thinking. The goal was to find a safe dose that could ease symptoms of early Alzheimer's…

This study followed over 1,100 older adults with normal memory, mild cognitive impairment, or early Alzheimer's to track how their thinking, memory, and brain scans change over time. Researchers used memory tests, brain imaging, and blood or spinal fluid samples to find better wa…